Skip to content

Organon OGN EV / EBITDA

EV / EBITDA at other companies

Pfizer logo
PfizerPFE
12.9×
Amgen logo
AmgenAMGN
15.9×-1.3×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
17.2×+0.2×
Biogen logo
BiogenBIIB
11.2×+2.8×
AbbVie logo
AbbVieABBV
19.8×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
16.6×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The official record: Organon’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Organon's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's EV / EBITDA?
Organon (OGN) reported EV / EBITDA of 8× in Q3 2025.
How has Organon's EV / EBITDA changed year-over-year?
Organon's EV / EBITDA decreased by 11.1% year-over-year, from 9× to 8×.
What is the long-term trend for Organon's EV / EBITDA?
Over 3 years (2021 to 2024), Organon's EV / EBITDA has grown at a -1.3% compound annual growth rate (CAGR), from 8.7× to 8.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.